| scholarly article | Q13442814 |
| P2093 | author name string | D Stern | |
| D Baum | |||
| M Szabolcs | |||
| J Brett | |||
| L Chess | |||
| A Matsushima | |||
| M J Yellin | |||
| P2860 | cites work | A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. | Q53548006 |
| Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. | Q55062376 | ||
| Induction of B cell costimulatory function by recombinant murine CD40 ligand | Q56909790 | ||
| Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes | Q67543297 | ||
| Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues | Q67684075 | ||
| CD40 is functionally expressed on human thymic epithelial cells | Q67898173 | ||
| Expression of activation antigens on T cells in rheumatoid arthritis patients | Q68932488 | ||
| Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation | Q71705974 | ||
| Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 | Q72093299 | ||
| Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity | Q72526692 | ||
| Differential expression of surface antigens on activated endothelium | Q72787968 | ||
| Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help) | Q24675460 | ||
| Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help | Q28179938 | ||
| Molecular and biological characterization of a murine ligand for CD40 | Q28186605 | ||
| A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells | Q28187669 | ||
| The CD40 antigen and its ligand | Q28286277 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| The distinct surface of human blood dendritic cells, as observed after an improved isolation method | Q30454169 | ||
| The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity | Q33938693 | ||
| T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity | Q34291986 | ||
| The understanding of contact-dependent T-cell helper function in molecular, cellular and physiological detail | Q34292932 | ||
| CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. | Q34324146 | ||
| Expression of the CD34 gene in vascular endothelial cells | Q34560816 | ||
| CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. | Q34721501 | ||
| Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50 | Q35612157 | ||
| Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells | Q35830543 | ||
| Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal | Q36361532 | ||
| Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines | Q36741294 | ||
| Immunologic interactions of T lymphocytes with vascular endothelium. | Q37512275 | ||
| The endothelial cell as a regulator of T-cell function | Q38009785 | ||
| The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune disease | Q40395341 | ||
| Is atherosclerosis an immunologically mediated disease? | Q40606541 | ||
| Endothelial-leukocyte adhesion molecules | Q40898249 | ||
| Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
| CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells | Q41691263 | ||
| Expression of functional CD40 by vascular endothelial cells | Q41981036 | ||
| Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes | Q42490090 | ||
| Cloning of TRAP, a ligand for CD40 on human T cells | Q48147375 | ||
| Further characterization of surface membrane structures expressed on human basophils and mast cells. | Q50884011 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1857-1864 | |
| P577 | publication date | 1995-12-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals | |
| P478 | volume | 182 |
| Q52843789 | A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation. |
| Q46310969 | A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes |
| Q54708794 | A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. |
| Q52025411 | Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets. |
| Q36367016 | Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. |
| Q48648841 | Analysis of a CD40 ligand dinucleotide microsatellite in multiple sclerosis |
| Q56897699 | Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies |
| Q35786333 | Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation |
| Q35161070 | Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype |
| Q33704386 | Brugia malayi microfilariae adhere to human vascular endothelial cells in a C3-dependent manner |
| Q40986859 | CD40 and its ligand in host defense |
| Q48415768 | CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium |
| Q28582086 | CD40 is expressed on rat peritoneal mesothelial cells and upregulates ICAM-1 production |
| Q80564571 | CD40 ligand gene and Kawasaki disease |
| Q52949259 | CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40–CD40L signalling in atherosclerosis |
| Q24310570 | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells |
| Q77723469 | CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation |
| Q47726341 | CD40 signaling in vascular cells: a key role in atherosclerosis? |
| Q28609312 | CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action |
| Q27481468 | CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis |
| Q47611649 | CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island |
| Q49025682 | CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of myelin basic protein-recognizing T cells in a model of progressive experimental autoimmune encephalomyelitis. |
| Q34082784 | CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. |
| Q41404432 | CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues |
| Q33814059 | CD40L and Its Receptors in Atherothrombosis-An Update |
| Q58754437 | Cerebral Malaria in Mouse and Man |
| Q99551803 | Characteristics and clinical trial results of agonistic anti-CD40 antibodies in the treatment of malignancies |
| Q37124739 | Clinical disease upregulates expression of CD40 and CD40 ligand on peripheral blood mononuclear cells from cattle naturally infected with Mycobacterium avium subsp. paratuberculosis |
| Q24674649 | Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages |
| Q35939463 | Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection |
| Q73225523 | Cytokine regulation of CD40 expression in fetal human astrocyte cultures |
| Q41472342 | Cytokine regulation of endothelial cell function: from molecular level to the bedside |
| Q28570672 | Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1 |
| Q24804920 | Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention |
| Q42484181 | Differential expression and regulation of murine CD40 in regional vascular beds |
| Q48848104 | Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. |
| Q35133638 | Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis |
| Q42472466 | Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. |
| Q43939775 | Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome |
| Q47688061 | Endothelial activation by cytokines |
| Q79209903 | Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis |
| Q79635270 | Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium |
| Q73344118 | Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions |
| Q36028683 | Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis |
| Q33734501 | Gene therapy in transplantation |
| Q48599233 | HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas |
| Q34386107 | Immunological aspects of microglia: relevance to Alzheimer's disease |
| Q37516075 | Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles |
| Q35635302 | Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles |
| Q35025400 | Inflammation, kidney function and albuminuria in the Framingham Offspring cohort |
| Q35160907 | Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice |
| Q78951915 | Interaction of monocytes with vascular endothelial cells synergistically induces interferon gamma-inducible protein 10 expression through activation of specific cell surface molecules and cytokines |
| Q54396413 | Interactions between T lymphocytes and endothelial cells in allograft rejection. |
| Q44185705 | Involvement of CD40-CD40L signaling in postischemic lung injury |
| Q38874554 | Involvement of the cytoplasmic cysteine-238 of CD40 in its up-regulation of CD23 expression and its enhancement of TLR4-triggered responses |
| Q33337601 | Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS? |
| Q35824531 | Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients |
| Q73085661 | Locomotor properties of human germinal centre B cells: activation by anti-CD40 and IL-4 allows chemoattraction by anti-immunoglobulin |
| Q47348885 | Molecular characterization of hypoxia-hypothermia-conditioned human endothelial cells and their interaction with human monocytes |
| Q47798217 | Monocyte-derived CD40 expression is regulated by interferon-γ/interferon-γ receptor-1 pathway when acting as a bridge during their interaction with T cells and allogeneic endothelial cells |
| Q43182095 | New frontiers for platelet CD154. |
| Q28192292 | Opportunities for the treatment of inflammation in cardiovascular disease |
| Q27021141 | Participation of blood vessel cells in human adaptive immune responses |
| Q34275978 | Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. |
| Q41124588 | Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney |
| Q34276030 | Potential biologic agents for treating rheumatoid arthritis |
| Q40183059 | Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-gamma-mediated up-regulation of CD40 signalling |
| Q24316540 | Reduction of atherosclerosis in mice by inhibition of CD40 signalling |
| Q56943378 | Regulation of endothelial cell function by pro- and anti-inflammatory cytokines |
| Q52536870 | Requirement for CD154 in the progression of atherosclerosis. |
| Q33338408 | Role of CD40-CVD40L in mouse severe malaria |
| Q28573892 | STAT-1 decoy oligonucleotide improves microcirculation and reduces acute rejection in allogeneic rat small bowel transplants |
| Q33345510 | Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura |
| Q26774645 | T Lymphocyte-Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity |
| Q34108813 | T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules |
| Q35754623 | T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation |
| Q35830859 | Targeting CD40L: a promising therapeutic approach |
| Q40421904 | Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis |
| Q41361342 | The CD40 ligand. At the center of the immune universe? |
| Q41642375 | The CD40 pathway in allograft rejection, acceptance, and tolerance |
| Q24673258 | The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future |
| Q41587176 | The CD40-CD154 system in anti-infective host defense |
| Q57240725 | The Labyrinthine Ways of Cancer Immunotherapy–T Cell, Tumor Cell Encounter: “How Do I Lose Thee? Let Me Count the Ways” |
| Q53321210 | The Use of Anti-CD40 mAb in Cancer. |
| Q40452360 | The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions? |
| Q35822234 | The local physicochemical environment conditions the proinflammatory response of endothelial cells and thus modulates leukocyte recruitment |
| Q47933342 | The role of germinal centers for antiviral B cell responses |
| Q33858548 | The soluble CD40 ligand sCD154 in systemic lupus erythematosus |
| Q38026924 | The use of agonistic anti-CD40 therapy in treatments for cancer |
| Q36427948 | Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway |
| Q43108657 | Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice |
| Q33790067 | Vasculitides secondary to systemic diseases |
Search more.